Filgrastim: all 430 studies that test it
Page 3 of 5. Open to participants first (38), then studies with results posted, then the rest; newest registration first within each.
- G-CSF Plus NAC In Severe Alcoholic HepatitisStatus unknownNCT02971306Phase 4
- Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesCompletedNCT02960646Phase 1
- G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant TumorStatus unknownNCT02933333Phase 4
- Clinical Phase II Trial to Evaluate CD34+ Cells Mobilization and Collection in Patients With Fanconi Anemia for Subsequent Transduction With a Lentiviral Vector Carring FANCA Gene. FANCOSTEM-1CompletedNCT02931071Phase 2
- A Study in Healthy Volunteers to Assess Immune Response to Multiple Injections of Filgrastim Hospira or Neupogen Reference Product.CompletedNCT02923791Phase 1
- G-CSF and Autologous Cord Blood Infusion in Cerebral PalsyStatus unknownNCT02866331Phase 2
- The Efficacy of G-CSF Against Adhesion Reformation After Hysteroscopic AdhesiolysisStatus unknownNCT02855632Not applicable
- A Clinical Trial of Omacetaxine, Azacitidine, and Growth-Colony Stimulating Factor (G-CSF) for Myelodysplastic Syndromes (MDS)WithdrawnNCT02835794Phase 1/2
- A Study to Compare Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Febrile NeutropeniaCompletedNCT02816164Phase 4
- Granulocyte-colony Stimulating Factors or Antibiotics for Primary Prophylaxis for Febrile NeutropeniaCompletedNCT02816112Phase 4
- Proteomics and Stem Cell Therapy as a New Vascularization StrategyCompletedNCT02802852Not applicable
- Filgrastim for Premature Ovarian InsufficiencyCompletedNCT02783937Phase 4
- A Research Study To Test How Filgrastim Hospira Works In The Body Of Healthy Study Subjects When Given By Subcutaneous Injection (Shot) Compared To An Already U.S.-Approved Drug Neupogen® (Amgen)CompletedNCT02766647Phase 1
- A Research Study To Test How Multiple Doses Of Filgrastim Hospira Works In The Body Of Healthy Study Subjects When Given by Subcutaneous Injection (SC) (Shot) Compared To An Already U.S.-Approved Drug Neupogen® (Amgen)CompletedNCT02766634Phase 1
- G-CSF in the Treatment of Toxic Epidermal NecrolysisCompletedNCT02739295Phase 4
- Evaluation of Pharmacokinetic/Pharmacodynamic Properties and Safety of Leucostim® Compared to Neupogen® in Healthy Adult VolunteersCompletedNCT02725086Phase 1
- Randomized Trial of G-CSF Alone Versus Intermediate-dose Ara-C Plus G-CSF Mobilization in Hodgkin's Lymphoma or Non-Hodgkin's LymphomaStatus unknownNCT02722733Phase 3
- A Study to Evaluate the PK, Safety and Tolerability of GMI-1271 With and Without Filgrastim in Healthy Adult SubjectsCompletedNCT02703051Phase 1
- Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)WithdrawnNCT02702960Phase 2
- Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC)TerminatedNCT02685111Phase 2
- Hyperbaric Oxygen Therapy for Hematopoietic Progenitor Cell Collection in Poor MobilizersWithdrawnNCT02682953Phase 2
- Mobilization and Collection of Peripheral Blood Stem Cells in Patients With Fanconi Anemia Using G-CSF and PlerixaforCompletedNCT02678533Phase 1/2
- Granulocyte Colony Stimulating Factor (G-CSF) to Treat Acute-on-chronic Liver FailureCompletedNCT02669680Not applicable
- A Phase II, Dose-finding Study of F-627 in Patients With Breast Cancer Receiving Myelotoxic Chemotherapy.CompletedNCT02521441Phase 2
- Granulocyte Colony Stimulating Factor And Growth Hormone In Cirrhosis Of Liver: An Open Label StudyCompletedNCT02451033Phase 2/3
- Allogeneic Stem Cell Transplantation for Patients With Multiple MyelomaWithdrawnNCT02447055Early Phase 1
- Efficacy and Safety of G-CSF in Patients With Severe Alcoholic Hepatitis With Null or Partial Response to SteroidTerminatedNCT02442180Phase 3
- Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell LymphomaActive, not recruitingNCT02436707Phase 2
- Granulocyte Colony Stimulating Factor (G-CSF) After Salvage Chemotherapy in Refractory AMLStatus unknownNCT02427919Phase 2/3
- Use Art-assist and Neupogen to Treat Chronic Limb IschemiaWithdrawnNCT02408991Phase 4
- HIV-Resistant Gene Modified Stem Cells and Chemotherapy in Treating Patients With Lymphoma With HIV InfectionWithdrawnNCT02343666Phase 1
- Combination Therapy of Cord Blood and G-CSF for Patients With Brain Injury or Neurodegenerative DisordersCompletedNCT02236065Not applicable
- Phase I Study of Bortezomib With G-CSF for Stem Cell Mobilization in Patients With Multiple MyelomaCompletedNCT02220608Phase 1
- REaCT Integrated Consent Model to Compare Two Standard of Care RegimensCompletedNCT02173262Phase 4
- Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor SourceCompletedNCT02167958Phase 1
- Gcsf Injection in Women With Repeated Implantaiton FailureTerminatedNCT02149277Phase 3
- Bone Marrow Stem Cell Treatment for Asherman's Syndrome and Endometrial AtrophyCompletedNCT02144987Phase 4
- A Phase 2 Trial of Filanesib in Relapsed/Refractory Multiple Myeloma (AfFIRM)CompletedNCT02092922Phase 2
- Combination of G-CSF, Bortezomib, Cyclophosphamide and Dexamethasone in Patients With Multiple MyelomaStatus unknownNCT02027220Phase 2
- Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in Children and AdolescentsStatus unknownNCT02014506Phase 1/2
- A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple MyelomaCompletedNCT01989325Phase 2
- STem cElls Mobilization in Acute Myocardial Infarction Outcome TrialTerminatedNCT01969890Phase 3
- Saftey and Efficacy of Pegfilgrastim in Preventing Chrmotherapy-induced NeutropeniaStatus unknownNCT01918241Phase 2
- Randomized Trial of G-CSF Alone Versus Intermediate-dose Ara-C Plus G-CSF Mobilization in Multiple Myeloma Patients.CompletedNCT01908621Phase 3
- A Trial to Study the Influence of Growth Factors on Bone Marrow and Hepatic Regeneration in Patients With Decompensated Cirrhosis.CompletedNCT01902511Not applicable
- First Line Treatment Trial in Multiple Myeloma, Finnish Myeloma Group- Multiple Myeloma 02CompletedNCT01790737Phase 2
- Donor Natural Killer Cells in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT01787474Phase 1
- Dose Adjusted EPOCH-R, to Treat Mature B Cell MalignanciesCompletedNCT01760226Early Phase 1
- Haploidentical Stem Cell Transplantation for Children With Acquired Severe Aplastic AnemiaStatus unknownNCT01759732Phase 2
- Risk Adapted Treatment for Primary Acute Myeloid Leukemia (AML)CompletedNCT01723657Phase 2
- Heparin Binding Protein in Patients With Acute Respiratory Failure Treated With GCSF (Filgrastim)CompletedNCT01713309Phase 2/3
- Mobilization of Stem Cells With G-CSF and Mozobil in Patients With End Stage Liver DiseaseStatus unknownNCT01711073Phase 1
- Expanded Cord Blood Cell Infusion Following Combination Chemotherapy in Younger Patients With Relapsed or Refractory Acute Myeloid LeukemiaTerminatedNCT01701323Phase 1
- Evaluation of Pharmacokinetic and Pharmacodynamic Parameters of Filgrastim (G-CSF)Produced by Blausiegel Indústria e Comércio Ltda. Compared to Granulokine Produced by Produtos Roche Químicos e Farmacêuticos S/A.CompletedNCT01549301Phase 1
- Safety and Efficacy of TXA127 and Neupogen to Increase Peripheral Blood Stem Cells (PBSCs)CompletedNCT01543971Phase 1
- Filgrastim in Treating Patients With Bortezomib-, Carfilzomib-, or IMID-Refractory Multiple MyelomaTerminatedNCT01537861Early Phase 1
- ALT-801-activated Natural Killer Cells After FLAG Induction for Acute Myeloid LeukemiaWithdrawnNCT01478074Phase 1
- Treatment of Relapsed or Refractory Acute Myeloblastic LeukemiaCompletedNCT01435343Phase 1/2
- Healthy Donor Study II - Comparing Plerixafor With G-CSF and PlerixaforCompletedNCT01403896Phase 2
- G-CSF and Erythropoetin in Survival of Patients With Decompensated Liver DiseaseCompletedNCT01384565Phase 3
- The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBCStatus unknownNCT01378533Phase 3
- Disrupting the Bone Marrow Microenvironment With G-CSF in Acute Lymphoblastic LeukemiaCompletedNCT01331590Early Phase 1
- Gene Therapy for Fanconi AnemiaTerminatedNCT01331018Phase 1
- Use of Granulocyte Colony-stimulating Factor for the Treatment of Recurrent Implantation Failure in IVF PatientsStatus unknownNCT01315470Phase 1
- Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Chemotherapy for LeukemiaCompletedNCT01297543Phase 1/2
- SubCutaneous (SC) Versus Intravenous (IV) Granulocyte Colony Stimulating Factors (G-CSF) for the Treatment of Neutropenia in Hospitalized Haemato-oncological PatientsTerminatedNCT01222819Phase 4
- PAV-trial: Plerixafor and Chemotherapy With Vinorelbine for Stem Cell Mobilization in Patients With MyelomaCompletedNCT01220375Phase 2
- Comparison Study of Standard Care Against Combination of Growth Factors Agents for Low-risk Myelodysplastic SyndromesCompletedNCT01196715Phase 3
- Plerixafor Harvesting And No Chemotherapy for Transplantation of Autologous STem Cells In Cancer (PHANTASTIC)CompletedNCT01186224Not applicable
- A Safety Study Looking at the Combination of Velcade and G-CSF in Patients With Myeloma or LymphomaCompletedNCT01171092Early Phase 1
- Randomized Study In Severe Aplastic Anemia Patients Receiving Atg, Cyclosporin A, With Or Without G-CSF (SAA-G-CSF)TerminatedNCT01163942Phase 3
- A Non-inferiority Study Comparing Two Filgrastim Preparations in Breast CancerCompletedNCT01079676Phase 3
- Plerixafor and Filgrastim Following Cyclophosphamide for Stem Cell Mobilization in Patients With Multiple MyelomaCompletedNCT01074060Phase 1
- Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) in Combination With Azacitidine for the Treatment of Myelodysplastic Syndrome (MDS)CompletedNCT01065129Phase 1
- Clofarabine, Cytarabine, and Filgrastim Followed by Infusion of Non-HLA Matched Ex Vivo Expanded Cord Blood Progenitors in Treating Patients With Acute Myeloid LeukemiaCompletedNCT01031368Phase 1
- Granulocyte Colony-stimulating Factor (G-CSF) Plus or Minus AMD3100 for Engraftment Post Allogeneic TransplantCompletedNCT01026987Phase 1
- Stem Cell Factor (SCF) Priming of Haematopoietic Stem Cell Grafts in Malignant LymphomaTerminatedNCT01016795Phase 2
- Granulocyte-colony Stimulating Factor (G-CSF) and Plerixafor Plus Sorafenib for Acute Myelogenous Leukemia (AML) With FLT3 MutationsCompletedNCT00943943Phase 1
- Study on the Incidence of Febrile Episodes During Stem Cells Collection After Chemotherapy in Patients With Multiple MyelomaStatus unknownNCT00932217Phase 3
- AXIS 2: AX200 for the Treatment of Ischemic StrokeCompletedNCT00927836Phase 2
- Granulocyte-colony Stimulating Factor for Stem Cells Therapy for Acute Ischemic StrokeCompletedNCT00901381Phase 2
- Induction With or Without Granulocyte Colony-Stimulating Factor in AML Transplantation in AMLCompletedNCT00820976Phase 3
- Study to Determine The Effect of a Drug Called Neupogen on Stroke RecoveryStatus unknownNCT00809549Phase 1
- Stem Cell Mobilization by G-CSF to Treat Severe Peripheral Artery DiseaseCompletedNCT00797056Early Phase 1
- Use of G-CSF for the Treatment of Unexplained Recurrent MiscarriageCompletedNCT00772122Phase 4
- G-CSF in Preventing Neutropenia in Women Receiving Chemotherapy for Breast CancerCompletedNCT00771433Phase 2
- G-CSF in Preventing Neutropenia in Patients With Solid Tumors Who Are Receiving ChemotherapyCompletedNCT00770172Phase 3
- The Effect of Granulocyte Colony Stimulating Factor (G-CSF) on Myocardial Function After Acute Anterior Myocardial Infarction, a Prospective Double Blind Randomized Placebo Controlled StudyCompletedNCT00756756Not applicable
- Concomitant Chemoradiotherapy With Weekly Paclitaxel and Vinorelbine and Granulocyte Colony Stimulating Factor (GCSF) Support in Patients With Advanced Breast CancerCompletedNCT00724386Phase 1
- Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin LymphomaCompletedNCT00678327Phase 3
- Adjuvant Treatment of Breast Cancer With 1-3 Aflicted Lymph NodesCompletedNCT00668616Phase 3
- Nonmyeloablative Allo SCT for the Treatment of Hematologic DisordersCompletedNCT00636909Phase 2
- MT2004-30: Tomotherapy for Solid TumorsTerminatedNCT00623077Phase 1
- PR104 and G-CSF in Treating Patients With Solid TumorsCompletedNCT00616213Phase 1
- Filgrastim for the Promotion of Collateral Growth in Patients With CADCompletedNCT00596479Not applicable
- High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Multiple MyelomaStatus unknownNCT00526734Phase 2
- Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCTCompletedNCT00516152Phase 2
- Cord Blood Expansion on Mesenchymal Stem CellsCompletedNCT00498316Phase 1
- Autologous Stem Cell Transplants for Chronic Myelogenous LeukemiaWithdrawnNCT00446173Phase 2
- Cell Therapy in Chagas CardiomyopathyTerminatedNCT00349271Phase 3